News Conference News ESC 2022 ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention Shelley Wood August 27, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed Todd Neale August 12, 2022
News Daily News Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race Yael L. Maxwell August 09, 2022
News Daily News USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits Michael O'Riordan July 27, 2022
News Daily News Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy Todd Neale July 20, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Desperate for Relief, Long COVID Patients Seek Apheresis, Other Untested Therapies Todd Neale July 14, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT Caitlin E. Cox July 08, 2022
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Daily News Weekend Warriors vs Regular Exercisers: Some Insights, More Questions Yael L. Maxwell July 06, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Daily News Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR Michael O'Riordan June 24, 2022
News Daily News USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits Yael L. Maxwell June 23, 2022
News Daily News Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE Michael O'Riordan June 17, 2022